UK Markets open in 3 hrs 42 mins
NIKKEI 225
27,719.32 +209.86 (+0.76%) HANG SENG
21,160.32 -500.15 (-2.31%) CRUDE OIL
73.51 +0.12 (+0.16%) GOLD FUTURES
1,889.10 +12.50 (+0.67%) DOW
33,926.01 -127.89 (-0.38%) BTC-GBP
19,019.19 -433.77 (-2.23%)
SWEDISH ORPHAN BIOVIT.SK1 (B6E.HA)
Hanover - Hanover Delayed price. Currency in EUR
Add to watchlist
At close: 08:00AM CET
| Previous close | 20.21 |
| Open | 20.22 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 20.22 - 20.22 |
| 52-week range | 16.50 - 22.78 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Swedish Orphan Biovitrum (BIOVF) Beats Q3 Earnings Estimates
Swedish Orphan Biovitrum (BIOVF) delivered earnings and revenue surprises of 16.67% and 2.26%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Are Medical Stocks Lagging Alimera Sciences (ALIM) This Year?
Here is how Alimera Sciences (ALIM) and Swedish Orphan Biovitrum (BIOVF) have performed compared to their sector so far this year.
- Zacks
Is Swedish Orphan Biovitrum (BIOVF) Stock Outpacing Its Medical Peers This Year?
Here is how Swedish Orphan Biovitrum (BIOVF) and CymaBay Therapeutics Inc. (CBAY) have performed compared to their sector so far this year.
© 2023 Yahoo. All rights reserved.
